Fineschi V, Monasterolo G, Rosi R, Turillazzi E (1999). „Fatal anaphylactic shock during a fluorescein angiography”. Forensic Sci. Int.100 (1–2), 137–42. o. DOI:10.1016/S0379-0738(98)00205-9. PMID10356782.
Hitosugi M, Omura K, Yokoyama T, Kawato H, Motozawa Y, Nagai T, Tokudome S (2004). „An autopsy case of fatal anaphylactic shock following fluorescein angiography: a case report”. Med Sci Law44 (3), 264–5. o. DOI:10.1258/rsmmsl.44.3.264. PMID15296251.
Kwan AS, Barry C, McAllister IL, Constable I (2006). „Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience”. Clin. Experiment. Ophthalmol.34 (1), 33–8. o. DOI:10.1111/j.1442-9071.2006.01136.x. PMID16451256.
Yang CS, Sung CS, Lee FL, Hsu WM (2007). „Management of anaphylactic shock during intravenous fluorescein angiography at an outpatient clinic”. J Chin Med Assoc70 (8), 348–9. o. DOI:10.1016/S1726-4901(08)70017-0. PMID17698436.
el Harrar N, Idali B, Moutaouakkil S, el Belhadji M, Zaghloul K, Amraoui A, Benaguida M (1996). „[Anaphylactic shock caused by application of fluorescein on the ocular conjunctiva]” (francia nyelven). Presse Med25 (32), 1546–7. o. PMID8952662.
Fineschi V, Monasterolo G, Rosi R, Turillazzi E (1999). „Fatal anaphylactic shock during a fluorescein angiography”. Forensic Sci. Int.100 (1–2), 137–42. o. DOI:10.1016/S0379-0738(98)00205-9. PMID10356782.
Hitosugi M, Omura K, Yokoyama T, Kawato H, Motozawa Y, Nagai T, Tokudome S (2004). „An autopsy case of fatal anaphylactic shock following fluorescein angiography: a case report”. Med Sci Law44 (3), 264–5. o. DOI:10.1258/rsmmsl.44.3.264. PMID15296251.
Kinsella FP, Mooney DJ (1988). „Anaphylaxis following oral fluorescein angiography”. Am. J. Ophthalmol.106 (6), 745–6. o. PMID3195657.
Gómez-Ulla F, Gutiérrez C, Seoane I (1991). „Severe anaphylactic reaction to orally administered fluorescein”. Am. J. Ophthalmol.112 (1), 94. o. PMID1882930.
Kwan AS, Barry C, McAllister IL, Constable I (2006). „Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience”. Clin. Experiment. Ophthalmol.34 (1), 33–8. o. DOI:10.1111/j.1442-9071.2006.01136.x. PMID16451256.
Jennings BJ, Mathews DE (1994). „Adverse reactions during retinal fluorescein angiography”. J Am Optom Assoc65 (7), 465–71. o. PMID7930354.
Matsuura M, Ando F, Fukumoto K, Kyogane I, Torii Y, Matsuura M (1996). „[Usefulness of the prick test for anaphylactoid reaction in intravenous fluorescein administration]” (japán nyelven). Nippon Ganka Gakkai Zasshi100 (4), 313–7. o. PMID8644545.
Ellis PP, Schoenberger M, Rendi MA (1980). „Antihistamines as prophylaxis against side reactions to intravenous fluorescein”. Trans Am Ophthalmol Soc78, 190–205. o. PMID7257056. PMC1312139.
Yang CS, Sung CS, Lee FL, Hsu WM (2007). „Management of anaphylactic shock during intravenous fluorescein angiography at an outpatient clinic”. J Chin Med Assoc70 (8), 348–9. o. DOI:10.1016/S1726-4901(08)70017-0. PMID17698436.
Ellis PP, Schoenberger M, Rendi MA (1980). „Antihistamines as prophylaxis against side reactions to intravenous fluorescein”. Trans Am Ophthalmol Soc78, 190–205. o. PMID7257056. PMC1312139.
uspto.gov
patft.uspto.gov
Brush, C. K. Fluorescein Labelled Phosphoramidites. US Patent 5,583,236. [1]Archiválva2017. február 6-i dátummal a Wayback Machine-ben